Gastrointestinal dysplasia

Poonam K Sharma, Elizabeth Montgomery

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The term dysplasia (intraepithelial neoplasia) is used to refer to neoplastic but non-invasive epithelium. Dysplasia in the gastrointestinal tract is considered a carcinoma precursor and a marker of high cancer risk for the site at which it is found. It is diagnosed by pathologists using a set of cytological and architectural features. There are many pitfalls in the diagnosis of gastrointestinal dysplasia. One reason for difficulty in dysplasia diagnosis is the significant heterogeneity in the appearances of each grade of dysplasia. In addition, the features that characterise dysplasia are only subtly different from those of regenerating epithelium, particularly at the low end of the spectrum, making this distinction difficult. For these reasons, and because of significant implications of this diagnosis for patient care, the interpretations of biopsies taken for dysplasia surveillance are considered challenging by most pathologists. In this article, we review definition, classification, and histological features and grading of gastrointestinal dysplasia with focus on Barrett's oesophagus (BE) related dysplasia, gastric epithelial dysplasia (GED) and dysplasia arising in the background of inflammatory bowel disease (IBD). We also discuss observer variability and the role of adjunctive markers in dysplasia diagnosis, and limitation with regard to surveillance of patients with BE and IBD due to sampling error.

Original languageEnglish
Pages (from-to)273-285
Number of pages13
JournalPathology
Volume45
Issue number3
DOIs
StatePublished - Apr 2013

Fingerprint

Barrett Esophagus
Inflammatory Bowel Diseases
Epithelium
Selection Bias
Gastrointestinal Tract
Neoplasms
Stomach
Patient Care
Carcinoma
Biopsy
Pathologists

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Gastrointestinal dysplasia. / Sharma, Poonam K; Montgomery, Elizabeth.

In: Pathology, Vol. 45, No. 3, 04.2013, p. 273-285.

Research output: Contribution to journalArticle

Sharma, Poonam K ; Montgomery, Elizabeth. / Gastrointestinal dysplasia. In: Pathology. 2013 ; Vol. 45, No. 3. pp. 273-285.
@article{e5e9c128faea4b68a4918d6f8fddbaca,
title = "Gastrointestinal dysplasia",
abstract = "The term dysplasia (intraepithelial neoplasia) is used to refer to neoplastic but non-invasive epithelium. Dysplasia in the gastrointestinal tract is considered a carcinoma precursor and a marker of high cancer risk for the site at which it is found. It is diagnosed by pathologists using a set of cytological and architectural features. There are many pitfalls in the diagnosis of gastrointestinal dysplasia. One reason for difficulty in dysplasia diagnosis is the significant heterogeneity in the appearances of each grade of dysplasia. In addition, the features that characterise dysplasia are only subtly different from those of regenerating epithelium, particularly at the low end of the spectrum, making this distinction difficult. For these reasons, and because of significant implications of this diagnosis for patient care, the interpretations of biopsies taken for dysplasia surveillance are considered challenging by most pathologists. In this article, we review definition, classification, and histological features and grading of gastrointestinal dysplasia with focus on Barrett's oesophagus (BE) related dysplasia, gastric epithelial dysplasia (GED) and dysplasia arising in the background of inflammatory bowel disease (IBD). We also discuss observer variability and the role of adjunctive markers in dysplasia diagnosis, and limitation with regard to surveillance of patients with BE and IBD due to sampling error.",
author = "Sharma, {Poonam K} and Elizabeth Montgomery",
year = "2013",
month = "4",
doi = "10.1097/PAT.0b013e32835f21d7",
language = "English",
volume = "45",
pages = "273--285",
journal = "Pathology",
issn = "0031-3025",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Gastrointestinal dysplasia

AU - Sharma, Poonam K

AU - Montgomery, Elizabeth

PY - 2013/4

Y1 - 2013/4

N2 - The term dysplasia (intraepithelial neoplasia) is used to refer to neoplastic but non-invasive epithelium. Dysplasia in the gastrointestinal tract is considered a carcinoma precursor and a marker of high cancer risk for the site at which it is found. It is diagnosed by pathologists using a set of cytological and architectural features. There are many pitfalls in the diagnosis of gastrointestinal dysplasia. One reason for difficulty in dysplasia diagnosis is the significant heterogeneity in the appearances of each grade of dysplasia. In addition, the features that characterise dysplasia are only subtly different from those of regenerating epithelium, particularly at the low end of the spectrum, making this distinction difficult. For these reasons, and because of significant implications of this diagnosis for patient care, the interpretations of biopsies taken for dysplasia surveillance are considered challenging by most pathologists. In this article, we review definition, classification, and histological features and grading of gastrointestinal dysplasia with focus on Barrett's oesophagus (BE) related dysplasia, gastric epithelial dysplasia (GED) and dysplasia arising in the background of inflammatory bowel disease (IBD). We also discuss observer variability and the role of adjunctive markers in dysplasia diagnosis, and limitation with regard to surveillance of patients with BE and IBD due to sampling error.

AB - The term dysplasia (intraepithelial neoplasia) is used to refer to neoplastic but non-invasive epithelium. Dysplasia in the gastrointestinal tract is considered a carcinoma precursor and a marker of high cancer risk for the site at which it is found. It is diagnosed by pathologists using a set of cytological and architectural features. There are many pitfalls in the diagnosis of gastrointestinal dysplasia. One reason for difficulty in dysplasia diagnosis is the significant heterogeneity in the appearances of each grade of dysplasia. In addition, the features that characterise dysplasia are only subtly different from those of regenerating epithelium, particularly at the low end of the spectrum, making this distinction difficult. For these reasons, and because of significant implications of this diagnosis for patient care, the interpretations of biopsies taken for dysplasia surveillance are considered challenging by most pathologists. In this article, we review definition, classification, and histological features and grading of gastrointestinal dysplasia with focus on Barrett's oesophagus (BE) related dysplasia, gastric epithelial dysplasia (GED) and dysplasia arising in the background of inflammatory bowel disease (IBD). We also discuss observer variability and the role of adjunctive markers in dysplasia diagnosis, and limitation with regard to surveillance of patients with BE and IBD due to sampling error.

UR - http://www.scopus.com/inward/record.url?scp=84879682687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879682687&partnerID=8YFLogxK

U2 - 10.1097/PAT.0b013e32835f21d7

DO - 10.1097/PAT.0b013e32835f21d7

M3 - Article

C2 - 23442738

AN - SCOPUS:84879682687

VL - 45

SP - 273

EP - 285

JO - Pathology

JF - Pathology

SN - 0031-3025

IS - 3

ER -